A new study highlighted by Veterans Exploring Treatment Solutions (VETS) suggests that former service members continue to benefit from magnesium-ibogaine therapy one year after treatment. Stanford Medicine’s follow-up, featured in Translational Psychiatry, shows sustained improvements in disability measures—signaling a promising development in veterans’ health care.